Writing the Future of Cell Therapies using the Twist Biopharma Library of Libraries

Time: 11:15 am
day: Day 2 - Track A - Morning


  • Utilising its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody and TCR discovery libraries including both
    (1) highly diverse synthetic naïve scFv and VHH antibody phage display libraries to discover targeting domains for CAR-T constructs, and
    (2) combinatorically assembled TCR libraries from gene fragments
  • In this talk, Aaron Sato, CSO, will present several POC data on how these technologies can be utilised for cell therapies